Product Safety Recalls

Product Recall Tracker

CYSTEINE HYDROCHLORIDE Recall D-0118-2024

Description: ELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Dose Sterile Vials, For Intravenous Infusion Only, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial: NDC 51754-1007-1; Carton: 51754-1007-3).

CYSTEINE HYDROCHLORIDE Recall D-0118-2024 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0118-2024
Event ID93265
BrandELCYS
Generic NameCYSTEINE HYDROCHLORIDE
ManufacturerCYSTEINE HYDROCHLORIDE
Original Package?1
Active SubstanceCYSTEINE HYDROCHLORIDE
Drug RouteINTRAVENOUS
DistributionNationwide
Quantity38,200 vials
Recall ReasonPresence of Particulate Matter: Silicone
Drug ClassificationClass I
Drug Code Info20231129
Product NDC51754-1007
Recall Initiation Date20231018
Report Date20231129
Classification Date20231122
Address1245 Blowing Rock Blvd
Lenoir, NC 28645-3618
United States
Recalling FirmExela Pharma Sciences LLC
Initial Notification Letter
Unique Ingredient IdentifierZT934N0X4W
Drug Application NumberNDA210660
Structured Product Labeling (SPL ID)3f3dc2d1-9383-4c95-b97a-3e25c588d8a4
Structured Product Labeling (SPL Set ID)e7652275-1c53-490c-82ad-e63867df5788
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.